Skip to main content
. 2023 Jan 19;15(2):345. doi: 10.3390/pharmaceutics15020345

Figure 1.

Figure 1

Using SCR technology for rapid TE and bone construction, LcRGD-peptide-modified demineralized bone matrix (DBM) exhibits a superior ability to adhere to cell surfaces and promote osteoinduction.